Iguana Healthcare Management’s Ligand Pharmaceuticals LGND Stock Holding History

Iguana Healthcare Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-56,105	Closed	-$2.7M	–	79
2015 Q1	$2.7M	Buy	+56,105	New	+$2.15M	1.14%	33
2014 Q3	–	Sell	-80,150	Closed	-$3.12M	–	71
2014 Q2	$3.12M	Hold	80,150	–	–	1.45%	28
2014 Q1	$3.36M	Sell	80,150 -40,075	-33%	-$1.67M	1.56%	23
2013 Q4	$3.94M	Buy	+120,225	New	+$3.92M	2.25%	14

Other funds holding LGND

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Iguana Healthcare Management's LGND Position: Q2 2015 in Review

Iguana Healthcare Management sold out of Ligand Pharmaceuticals (LGND) in Q2 2015, closing a stake of 56,105 shares — an estimated $2.7M sold.

Iguana Healthcare Management first reported a position in LGND in Q4 2013 and held it in 4 quarters. The position peaked at $3.94M in Q4 2013. 215 funds tracked by Wall St. Rank hold LGND as of Q2 2015.

Iguana Healthcare Management reported no remaining Ligand Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Iguana Healthcare Management sold 56,105 Ligand Pharmaceuticals shares in Q2 2015, an estimated $2.7M.
Iguana Healthcare Management first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 4 quarters.
Iguana Healthcare Management's Ligand Pharmaceuticals position peaked at $3.94M in Q4 2013.
215 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2015.

Based on Iguana Healthcare Management's 13F filing for Q2 2015, filed 14 Aug 2015.